Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7317 p379
18 September 2004

This article
Reprint   Photocopy

PDF 110K, Acrobat Reader

Letters

· Counterfeit drugs
· Packaging
· Simvastatin
· Shipman inquiry
· The register
· Personal control
· The Society
· New contract
· Employee pharmacists
· Tuberculosis
· Retention fee
· Overseas membership
· Onlooker


Letters to the Editor

Packaging

Always complain when things are unsatisfactory

From Mr D. J. Fallon, MRPharmS

It is good to see a pharmacist actively complaining about the poor quality of pack designs from APS (PJ, 21 August, p255).

Exactly five years ago, the concerns of pharmacists, including myself, about APS designs were strongly expressed in the PJ, and the sales and marketing director of APS, John Beighton, stated in reply to John Gentle (PJ, 14 August 1999, p240) that APS “took great care to involve community pharmacy in the design”, had “noted the concerns of your correspondent and others” and “are in the process of introducing more colours where there are potential identification problems”.

I spent some time at that stage speaking directly to Mr Beighton on the telephone, following a dispensing error that proved expensive to resolve, and wrote repeatedly to him from November 2000 onwards with a complete analysis of the faults of his pack designs and full advice on how to resolve all issues.

It is now clear that I wasted my time, and the statements made by APS were meaningless. I would encourage pharmacists to use their own judgement, and always complain when things are unsatisfactory.

Dennis Fallon
Birmingham

 

JOHN BEIGHTON, managing director, APS Berk, replies:

APS Berk’s packaging was indeed developed with the co-operation of our pharmacy customers and the development of the design over the past five years has always been with community pharmacy input. From 2000 we responded to customers’ comments by introducing more colours and stripes; we have also made the product names highly prominent on a white background and moved some of the information to make the “back of pack” less busy, and leave space for the dispensary label. We have introduced a random pattern on blister strips.

However, due to our growing range we have now made the decision to redesign our packs more radically and have recently had a meeting with the Medicines and Healthcare products Regulatory Agency to discuss pack design and the use of colour to differentiate between strengths and products. We do value the feedback of all our customers and are in the process of running focus groups in both community and hospital pharmacy, where this feedback is listened to and acted upon.

Send your letter to The Editor

Previous Topic (Counterfeit drugs)
Next Topic (Simvastatin)

Back to Top


©The Pharmaceutical Journal